Clinical Applications of EEG in Children

Talks

Brain maturation in children with autism spectrum disorder – overly rapid followed by too slow
J. Christopher Edgar, PhD
Done
State of the technology / What ANT does / What products are on the horizon
Dr. Frank Zanow
Done
Toward Enhancing Cognition in Real Time
John Medaglia, PhD
Done
Optimizing TMS Targeting and Treatment Response in Depression: Insights from Functional Connectivity and Induced Brain Activity Effects
Romain Duprat, PhD
Done
High-Intensity Targeted HD-tDCS for Motor Skill Learning
Gavin Hsu
Done
Insights Offered by Advanced Signal Processing Analysis of High-Density EEG of Term Low-risk Newborns
Dr. RB Govindan
Done
Personalized therapeutic brain-stimulation with real-time EEG-synchronized TMS
Christoph Zrenner, MD
Done
A near real-time computational engine for estimating TMS-induced electric fields with applications to mapping and beyond
Evgenii Kim, PhD
Done
Magnetoencephalography (MEG): Considerations vs. EEG for Clinical and Research Applications – A Moving Target?
Timothy P.L. Roberts
Done
Precision in TMS motor mapping and neuromodulation targeting: Clinical relevance and updates
Dylan Edwards, PhD
Done

Location: Lecture Hall - 4/10/24, 9:50 AM - 4/10/24, 10:20 AM (US/Eastern) (30 minutes)

Sudha Kilaru Kessler, MD, MSCE

Associate Professor of Neurology and Pediatrics at University of Pennsylvania and Children's Hospital of Philadelphia

Dr. Kessler is the Catherine D. Brown Chair for Pediatric Epilepsy and is an Associate Professor of Neurology and Pediatrics at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania. She is the Medical Director of the Epilepsy Surgery program at CHOP and the program director of the pediatric epilepsy fellowship. Her clinical and research efforts focus on clinical trial design and conduct, epilepsy surgery including implanted stimulation devices, noninvasive brain stimulation, epilepsy genetics, electroencephalography, magnetoencephalography, and outcome measures for epilepsy and other neurologic disorders. Her research has been supported by the NIH, FDA, and private foundations.